Goldman Sachs
ASPX

Goldman Sachs’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Goldman Sachs’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-18,785
Closed -$1.88M – 7672
2015
Q1 		$1.88M Buy
18,785
+14,092
+300% +$939K ﹤0.01% 3839
2014
Q4 		$246K Buy
+4,693
New +$138K ﹤0.01% 5975

Goldman Sachs's ASPX Position: Q2 2015 in Review

Goldman Sachs sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 18,785 shares — an estimated $1.88M sold.

Goldman Sachs first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $1.88M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Goldman Sachs reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Goldman Sachs sold 18,785 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.88M.
  • Goldman Sachs first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Goldman Sachs's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.88M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.